Exploiting the immunogenic potential of standard of care radiation or cisplatin therapy in preclinical models of HPV-associated malignancies

Joshua T Kowalczyk; Kellsye P Fabian; Michelle R Padget; Diana C Lopez; Austin TK Hoke; Clint T Allen; Mario Hermsen; Nyall R London,; James W Hodge

doi:10.1136/jitc-2022-005752

Article info

PDF

PDF +
Supplementary
Material

Clinical/translational cancer immunotherapy

Original research

Exploiting the immunogenic potential of standard of care radiation or cisplatin therapy in preclinical models of HPV-associated malignancies

Authors

Joshua T Kowalczyk Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA PubMed articles Google scholar articles
Kellsye P Fabian Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA PubMed articles Google scholar articles
Michelle R Padget Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA PubMed articles Google scholar articles
Diana C Lopez Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA PubMed articles Google scholar articles
Austin TK Hoke Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA PubMed articles Google scholar articles
Clint T Allen Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA PubMed articles Google scholar articles
Mario Hermsen Department Head and Neck Cancer, Centro de Investigación Biomédica en Red, Madrid, Spain PubMed articles Google scholar articles
Nyall R London, Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA Sinonasal and Skull Base Tumor Program, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, Maryland, USA Department of Otolaryngology - Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA PubMed articles Google scholar articles
James W Hodge Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA PubMed articles Google scholar articles

Citation

Kowalczyk JT, Fabian KP, Padget MR, et al

Exploiting the immunogenic potential of standard of care radiation or cisplatin therapy in preclinical models of HPV-associated malignancies

Journal for ImmunoTherapy of Cancer 2022;10:e005752. doi: 10.1136/jitc-2022-005752

Online issue publication

October 18, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password